Finance

Beta
Lists
ZVRA:NASDAQ
Zevra Therapeutics Inc
$11.59
+1.67%
(+0.19) 1D
$11.56
-0.26% (-0.030)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZVRA...
Open
$11.45
High
$11.74
Low
$11.36
Mkt. cap
685.14M
Avg. vol.
1.54M
Volume
2.26M
P/E ratio
5.72
52-wk high
$13.16
52-wk low
$7.16
EPS
$2.03
Beta
0.88
Shares outstanding
59.12M
No. of employees
61
Open
$11.45
High
$11.74
Low
$11.36
Mkt. cap
685.14M
Avg. vol.
1.54M
Volume
2.26M
P/E ratio
5.72
52-wk high
$13.16
52-wk low
$7.16
EPS
$2.03
Beta
0.88
Shares outstanding
59.12M
No. of employees
61
News stories
From sources across the web
About Zevra Therapeutics Inc
CEO-
Employees61
Founded2006
Headquarters-
SectorPharmaceutical industry
Websitezevra.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.18 / $0.08
+113.55%beat
Revenue / Est. (USD)
36.22M / 32.52M
+11.37%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
25.88M
26.06M
34.12M
36.22M
Cost of goods sold
12.38M
1.24M
1.52M
1.90M
Cost of revenue
12.38M
1.24M
1.52M
1.90M
Research and development expenses
3.43M
3.43M
2.52M
4.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.78M
16.94M
20.45M
20.78M
Operating expense
25.83M
20.68M
23.29M
25.49M
Total operating expenses
38.21M
21.92M
24.81M
27.39M
Operating income
-12.33M
4.14M
9.32M
8.83M
Other non operating income
-747.00K
-5.51M
3.56M
968.00K
EBT including unusual items
76.91M
-977.00K
12.67M
44.80M
EBT excluding unusual items
-12.71M
-1.10M
12.64M
11.68M
Income tax expense
2.20M
-433.00K
501.00K
6.91M
Effective tax rate
2.86%
44.32%
3.96%
15.43%
Other operating expenses
-
-
-
-
Net income
74.71M
-544.00K
12.16M
37.89M
Net profit margin
288.66%
-2.09%
35.65%
104.61%
Earnings per share
-0.06
-0.01
0.19
0.18
Interest and investment income
2.38M
2.31M
1.71M
3.59M
Interest expense
-2.01M
-2.05M
-1.95M
-1.71M
Net interest expenses
369.00K
262.00K
-236.00K
1.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.68M
4.54M
9.68M
9.20M
Gain or loss from assets sale
-148.32M
-
63.00K
-43.31M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer